Biomarker Strategies Logo


Homepage

 




Media Center and Key Milestones


February 2010 - BioMarker Strategies' CSO to Chair Panel on Functional Biomarkers at 2010 BIO Annual Meeting, Wed., May 5 from 8-9:30am More Information

February 2010 - Start-Up Magazine Profiles BioMarker Strategies Article

January 22, 2010 - BioMarker Strategies names former Vice-President of Maverick Capital, Christy Wyskiel, to its Board of Directors.
Press Release
| Baltimore Business Journal

2009

November 6, 2009 - Scott Allocco gives presentation at MD/DC/VA regional BIO meeting on "Biomarkers and Personalized Medicine: Challenges and Opportunities.”

November 2009 - Dr. Douglas P. Clark publishes scientific review titled: “Ex Vivo Biomarkers: Functional Tools to Guide Targeted Drug Development and Therapy,” Expert Review of Molecular Diagnostics 9(8), 787-794 (2009).

October, 17, 2009 - Dr. Douglas Clark presents at the 3rd Annual EORTC-NCI-ASCO Meeting on “Molecular Markers in Cancer” in Brussels, Belgium. Dr. Clark presented on the topic of Optimizing Information Obtained from Fine Needle Aspiration (FNA) Biopsies.” Dr. Clark also recently published an article on the utilization of FNA biopsies to inform targeted cancer therapy decisions in the October issue of Cancer Cytopathology.

October 7, 2009 - BioMarker Strategies Awarded Fast-Track SBIR for up to $2.3 million by National Cancer Institute Press Release

September 11, 2009 - BioMarker Strategies Announces $1.7 Million Raise, Including Investment by Abell Foundation Press Release

Press Coverage:
Baltimore Business Journal
Baltimore Sun

July 10, 2009 - Challenges of solid tumor biomarkers in drug development

Press Coverage:
Genetic Engineering & Biotechnology News

July 1, 2009 - Biomarker Strategies Lines Up for Maryland Investment Incentive Program

Press Coverage:
Baltimore Business Journal
Baltimore Sun
Washington Post

May 19, 2009 - BioMarker Strategies’ CSO gives presentation on predictive biomarkers at Annual BIO Meeting Press Release

Press Coverage of BIO Presentation:
Bioworld Today
Genetic Engineering & Biotechnology News
The InVivo Blog

April 27, 2009 - BioMarker Strategies Awarded Grant by Md TEDCO and Johnson & Johnson for SnapPath System Press Release

March 16–18, 2009
- Douglas P. Clark, MD, CSO, presented a talk entitled "Pre-analytical Variables Affecting FNA and Their Influence on Clinical Diagnosis" at the 2nd Annual NCI Biospecimen Research Network (BRN) Symposium: Advancing Cancer Research Through Biospecimen Science in Bethesda, MD

March 12, 2009 - Kären Olson, CEO, was awarded the “Leadership in BioScience Award” by The Greater Baltimore Committee (GBC). Press Release

2008

August 5, 2008- Scott Allocco, President, quoted in NY Times article "Building a Technology Park in Baltimore by Rehabilitating a Neighborhood"

July 9, 2008- Kären Olson named CEO of Biomarker Strategies

July 1, 2008- Biomarker Strategies files more than $1 million in tax credit applications to the State of Maryland (Press Coverage: Baltimore Sun and Washington Post)

June 19th, 2008- Dr. Douglas Clark, CSO, is a presenter at the National BIO Annual Meeting at a session titled: "Drug/Diagnostic Development-Clinical Validation and Personalized Medicine" View the Presentation

March 1, 2008- BioMarker Strategies joins Advamed (www.advamed.org), the national medical device industry association.

February 1, 2008- BioMarker Strategies joins the Personalized Medicine Coalition (www.personalizedmedicinecoalition.org).

January 1, 2008- BioMarker Strategies joins BIO, the National Biotechnology Industry Organization (www.bio.org). The company is also a member of the Maryland Tech Council/Maryland BIO.

2007

December 24, 2007- BioMarker Strategies signs lease to become one of the first commercial tenants of the Science & Technology Park at Johns Hopkins.

Press Coverage:
Baltimore Business Journal
Baltimore Daily Record
Forest City-New East Baltimore Partnership
Globest Newsletter

December 14, 2007- The company closes initial angel investment round after raising start-up capital from high net worth investors, including funds raised through the Maryland Biotech Investment Tax Credit Program.

March 2007- BioMarker Strategies signs sponsored research agreement with Johns Hopkins.

line

 

Please send media inquiries to info@biomarkerstrategies.com or you can contact Scott Allocco at 410-522-1008.

 

 

© 2010 Biomarker Strategies